Selected research
Market Structure
Global Mosapride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Mosapride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Mosapride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Mosapride include DAIICHI SANKYO, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., SAWAI PHARMACEUTICAL CO., LTD., Sumitomo Dainippon Pharma, Konghong Pharmaceutical, HAOSON PHARMA and Lunan Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Mosapride market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Mosapride and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Mosapride revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Mosapride market size, projected growth trends, production technologies, key applications, and end-use industries.
Mosapride Segment by Company
DAIICHI SANKYO
Dainippon Pharmaceutical Co., Ltd.
Nihon Generic
NIPPON CHEMIPHAR CO., LTD.
SAWAI PHARMACEUTICAL CO., LTD.
Sumitomo Dainippon Pharma
Konghong Pharmaceutical
HAOSON PHARMA
Lunan Pharmaceutical Group
Mosapride Segment by Type
Tablet
Capsule
Others
Mosapride Segment by Application
Gastritis
Dyspepsia
Others
Mosapride Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mosapride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mosapride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mosapride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Mosapride in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mosapride industry.
Chapter 3: Detailed analysis of Mosapride companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mosapriderevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Others
Applications
- Gastritis
- Dyspepsia
- Others
Companies covered
- DAIICHI SANKYO
- Dainippon Pharmaceutical Co., Ltd.
- Nihon Generic
- NIPPON CHEMIPHAR CO., LTD.
- SAWAI PHARMACEUTICAL CO., LTD.
- Sumitomo Dainippon Pharma
- Konghong Pharmaceutical
- HAOSON PHARMA
- Lunan Pharmaceutical Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Mosapride Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Tablet
- 1.2.3 Capsule
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Mosapride Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Gastritis
- 1.3.3 Dyspepsia
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Mosapride Growth Trends by Region
- 1.5.1 Global Mosapride Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Mosapride Market Size by Region (2021-2026)
- 1.5.3 Mosapride Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Mosapride Market Dynamics
- 2.1 Mosapride Industry Trends
- 2.2 Mosapride Industry Drivers
- 2.3 Mosapride Industry Opportunities and Challenges
- 2.4 Mosapride Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Mosapride Revenue by Company (2021-2026)
- 3.2 Global Mosapride Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Mosapride Key Company Head office and Area Served
- 3.4 Global Mosapride Company, Product Type & Application
- 3.5 Global Mosapride Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Mosapride Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Mosapride Players Market Share by Revenue in 2025
- 3.6.3 2025 Mosapride Tier 1, Tier 2, and Tier 3
4 Mosapride Market by Type
- 4.1 Global Mosapride Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Mosapride Market Size by Type (2021-2032)
- 4.3 Global Mosapride Market Size Share by Type (2021-2032)
5 Mosapride Market by Application
- 5.1 Global Mosapride Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Mosapride Market Size by Application (2021-2032)
- 5.3 Global Mosapride Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 DAIICHI SANKYO
- 6.1.1 DAIICHI SANKYO Company Information
- 6.1.2 DAIICHI SANKYO Business Overview
- 6.1.3 DAIICHI SANKYO Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 DAIICHI SANKYO Mosapride Product Portfolio
- 6.1.5 DAIICHI SANKYO Recent Developments
- 6.2 Dainippon Pharmaceutical Co., Ltd.
- 6.2.1 Dainippon Pharmaceutical Co., Ltd. Company Information
- 6.2.2 Dainippon Pharmaceutical Co., Ltd. Business Overview
- 6.2.3 Dainippon Pharmaceutical Co., Ltd. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Dainippon Pharmaceutical Co., Ltd. Mosapride Product Portfolio
- 6.2.5 Dainippon Pharmaceutical Co., Ltd. Recent Developments
- 6.3 Nihon Generic
- 6.3.1 Nihon Generic Company Information
- 6.3.2 Nihon Generic Business Overview
- 6.3.3 Nihon Generic Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Nihon Generic Mosapride Product Portfolio
- 6.3.5 Nihon Generic Recent Developments
- 6.4 NIPPON CHEMIPHAR CO., LTD.
- 6.4.1 NIPPON CHEMIPHAR CO., LTD. Company Information
- 6.4.2 NIPPON CHEMIPHAR CO., LTD. Business Overview
- 6.4.3 NIPPON CHEMIPHAR CO., LTD. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 NIPPON CHEMIPHAR CO., LTD. Mosapride Product Portfolio
- 6.4.5 NIPPON CHEMIPHAR CO., LTD. Recent Developments
- 6.5 SAWAI PHARMACEUTICAL CO., LTD.
- 6.5.1 SAWAI PHARMACEUTICAL CO., LTD. Company Information
- 6.5.2 SAWAI PHARMACEUTICAL CO., LTD. Business Overview
- 6.5.3 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 SAWAI PHARMACEUTICAL CO., LTD. Mosapride Product Portfolio
- 6.5.5 SAWAI PHARMACEUTICAL CO., LTD. Recent Developments
- 6.6 Sumitomo Dainippon Pharma
- 6.6.1 Sumitomo Dainippon Pharma Company Information
- 6.6.2 Sumitomo Dainippon Pharma Business Overview
- 6.6.3 Sumitomo Dainippon Pharma Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Sumitomo Dainippon Pharma Mosapride Product Portfolio
- 6.6.5 Sumitomo Dainippon Pharma Recent Developments
- 6.7 Konghong Pharmaceutical
- 6.7.1 Konghong Pharmaceutical Company Information
- 6.7.2 Konghong Pharmaceutical Business Overview
- 6.7.3 Konghong Pharmaceutical Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Konghong Pharmaceutical Mosapride Product Portfolio
- 6.7.5 Konghong Pharmaceutical Recent Developments
- 6.8 HAOSON PHARMA
- 6.8.1 HAOSON PHARMA Company Information
- 6.8.2 HAOSON PHARMA Business Overview
- 6.8.3 HAOSON PHARMA Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 HAOSON PHARMA Mosapride Product Portfolio
- 6.8.5 HAOSON PHARMA Recent Developments
- 6.9 Lunan Pharmaceutical Group
- 6.9.1 Lunan Pharmaceutical Group Company Information
- 6.9.2 Lunan Pharmaceutical Group Business Overview
- 6.9.3 Lunan Pharmaceutical Group Mosapride Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Lunan Pharmaceutical Group Mosapride Product Portfolio
- 6.9.5 Lunan Pharmaceutical Group Recent Developments
7 North America
- 7.1 North America Mosapride Market Size (2021-2032)
- 7.2 North America Mosapride Market Size by Type
- 7.2.1 North America Mosapride Market Size by Type (2021-2026)
- 7.2.2 North America Mosapride Market Size by Type (2027-2032)
- 7.2.3 North America Mosapride Market Share by Type (2021-2032)
- 7.3 North America Mosapride Market Size by Application
- 7.3.1 North America Mosapride Market Size by Application (2021-2026)
- 7.3.2 North America Mosapride Market Size by Application (2027-2032)
- 7.3.3 North America Mosapride Market Share by Application (2021-2032)
- 7.4 North America Mosapride Market Size by Country
- 7.4.1 North America Mosapride Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Mosapride Market Size by Country (2021-2026)
- 7.4.3 North America Mosapride Market Size by Country (2027-2032)
- 7.4.4 North America Mosapride Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Mosapride Market Size (2021-2032)
- 8.2 Europe Mosapride Market Size by Type
- 8.2.1 Europe Mosapride Market Size by Type (2021-2026)
- 8.2.2 Europe Mosapride Market Size by Type (2027-2032)
- 8.2.3 Europe Mosapride Market Share by Type (2021-2032)
- 8.3 Europe Mosapride Market Size by Application
- 8.3.1 Europe Mosapride Market Size by Application (2021-2026)
- 8.3.2 Europe Mosapride Market Size by Application (2027-2032)
- 8.3.3 Europe Mosapride Market Share by Application (2021-2032)
- 8.4 Europe Mosapride Market Size by Country
- 8.4.1 Europe Mosapride Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Mosapride Market Size by Country (2021-2026)
- 8.4.3 Europe Mosapride Market Size by Country (2027-2032)
- 8.4.4 Europe Mosapride Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Mosapride Market Size (2021-2032)
- 9.2 China Mosapride Market Size by Type
- 9.2.1 China Mosapride Market Size by Type (2021-2026)
- 9.2.2 China Mosapride Market Size by Type (2027-2032)
- 9.2.3 China Mosapride Market Share by Type (2021-2032)
- 9.3 China Mosapride Market Size by Application
- 9.3.1 China Mosapride Market Size by Application (2021-2026)
- 9.3.2 China Mosapride Market Size by Application (2027-2032)
- 9.3.3 China Mosapride Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Mosapride Market Size (2021-2032)
- 10.2 Asia Mosapride Market Size by Type
- 10.2.1 Asia Mosapride Market Size by Type (2021-2026)
- 10.2.2 Asia Mosapride Market Size by Type (2027-2032)
- 10.2.3 Asia Mosapride Market Share by Type (2021-2032)
- 10.3 Asia Mosapride Market Size by Application
- 10.3.1 Asia Mosapride Market Size by Application (2021-2026)
- 10.3.2 Asia Mosapride Market Size by Application (2027-2032)
- 10.3.3 Asia Mosapride Market Share by Application (2021-2032)
- 10.4 Asia Mosapride Market Size by Country
- 10.4.1 Asia Mosapride Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Mosapride Market Size by Country (2021-2026)
- 10.4.3 Asia Mosapride Market Size by Country (2027-2032)
- 10.4.4 Asia Mosapride Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Mosapride Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Mosapride Market Size by Type
- 11.2.1 South America, Middle East & Africa Mosapride Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Mosapride Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Mosapride Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Mosapride Market Size by Application
- 11.3.1 South America, Middle East & Africa Mosapride Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Mosapride Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Mosapride Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Mosapride Market Size by Country
- 11.4.1 South America, Middle East & Africa Mosapride Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Mosapride Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Mosapride Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Mosapride Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst